ASPH and neoplasm: Dendritic cell vaccination studies in a rodent model of biliary cancer showed successful passive vaccination with naïve dendritic cells that were matured in vivo in the presence of ASPH, leading to tumor regression, along with ASPH-specific T-cell responses (25).